lifestyle.pspl.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Editas Medicine, Inc.
Editas Medicine Announces First Quarter 2026 Results and Business Updates
May 7, 2026
Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences
May 6, 2026
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
May 2, 2026
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
May 2, 2026
Editas Medicine to Participate in Upcoming Investor Conferences
February 23, 2026